The P42 peptide and Peptide-based therapies for Huntington’s disease

Huntington’s disease (HD) is a progressive neurodegenerative hereditary disease clinically characterised by the presence of involuntary movements, behavioural problems and cognitive decline. The disease-onset ...
Source: Orphanet Journal of Rare Diseases - Category: Internal Medicine Authors: Source Type: research